Skip to main navigation Skip to search Skip to main content

Diagnosis and Management of Group 3 Pulmonary Hypertension in the UAE: Pulmonary Hypertension Associated with Chronic Lung Disease (PH-CLD)

  • Mediclinic Hospital
  • Brown University
  • Royal Health Heart Centre
  • Emirates Medical Association
  • Sheikh Tahnoon Medical City
  • United Arab Emirates University
  • Cleveland Clinic Abu Dhabi
  • Al Ain Hospital
  • Burjeel Royal and Mediclinic Hospitals

Research output: Contribution to journal › Review article › peer-review

Abstract

Chronic Lung Diseases (CLDs) constitute one of the most frequent causes of pulmonary hypertension (PH) and rank second after PH due to left heart disease. In PH-CLD, destruction of lung parenchyma is associated with decreased functional capacity, diminished quality of life, increased oxygen requirements, and a heightened risk of death. As both pulmonary arterial hypertension (PAH) and PH due to lung disease are categorized as precapillary PH, it is essential to distinguish between the two conditions, particularly when the lung disease is present with the severe form of PH. If the diagnosis confirms a severe form of PH-CLD, then individualised care is essential in patients with severe lung disease and evidence of right-sided heart failure, particularly those with lower-limb oedema. Moreover, echocardiography (ECHO) and N-terminal-pro hormone B-type natriuretic peptide (NT-proBNP) evaluation are of high importance and must be ordered by the pulmonologist. Right Heart Catheterisation (RHC) is also essential for the determination of the extent and severity of pulmonary vascular involvement. The use of inhaled vasodilators, along with a referral for right heart catheterisation, should be considered at an earlier phase of interstitial lung disease. In addition to therapy, cardiopulmonary rehabilitation programmes have been found to improve six-minute walking tests (6MWT), oxygenation, and functional capacity. This article discusses the screening of PH-CLD along with the treatment algorithm and suggests the promising role of vasodilators in PH-CLD.

Original languageEnglish
Article numbere02506882333573
JournalNew Emirates Medical Journal
Volume5
DOIs
StatePublished - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cardiopulmonary rehabilitation programmes
  • Chronic lung disease
  • Precapillary
  • Pulmonary hypertension
  • Right heart catheterization
  • Vasodilators

Fingerprint

Dive into the research topics of 'Diagnosis and Management of Group 3 Pulmonary Hypertension in the UAE: Pulmonary Hypertension Associated with Chronic Lung Disease (PH-CLD)'. Together they form a unique fingerprint.

Cite this